Concepts (253)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, Emission-Computed, Single-Photon | 87 | 2025 | 205 | 17.940 |
Why?
|
| Image Processing, Computer-Assisted | 60 | 2025 | 653 | 9.590 |
Why?
|
| Heart | 41 | 2024 | 275 | 7.800 |
Why?
|
| Phantoms, Imaging | 51 | 2025 | 217 | 6.230 |
Why?
|
| Myocardial Perfusion Imaging | 13 | 2024 | 51 | 5.730 |
Why?
|
| Artifacts | 23 | 2024 | 127 | 4.230 |
Why?
|
| Movement | 12 | 2019 | 149 | 4.050 |
Why?
|
| Respiration | 8 | 2018 | 88 | 2.710 |
Why?
|
| Algorithms | 35 | 2024 | 981 | 2.390 |
Why?
|
| Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography | 8 | 2018 | 10 | 2.140 |
Why?
|
| Brain | 11 | 2025 | 1495 | 2.000 |
Why?
|
| Technetium Tc 99m Sestamibi | 12 | 2022 | 33 | 1.790 |
Why?
|
| Radiopharmaceuticals | 15 | 2022 | 181 | 1.700 |
Why?
|
| Imaging, Three-Dimensional | 11 | 2021 | 278 | 1.680 |
Why?
|
| Image Enhancement | 15 | 2011 | 189 | 1.660 |
Why?
|
| Image Interpretation, Computer-Assisted | 10 | 2011 | 170 | 1.620 |
Why?
|
| Motion | 13 | 2024 | 56 | 1.610 |
Why?
|
| ROC Curve | 18 | 2024 | 268 | 1.460 |
Why?
|
| Perfusion | 8 | 2023 | 80 | 1.350 |
Why?
|
| Radiation Dosage | 5 | 2019 | 128 | 1.330 |
Why?
|
| Heart Ventricles | 9 | 2018 | 255 | 1.270 |
Why?
|
| Positron-Emission Tomography | 4 | 2014 | 200 | 1.240 |
Why?
|
| Computer Simulation | 20 | 2023 | 459 | 1.210 |
Why?
|
| Humans | 93 | 2025 | 59736 | 1.020 |
Why?
|
| Reproducibility of Results | 21 | 2023 | 1570 | 0.990 |
Why?
|
| Software | 4 | 2023 | 366 | 0.760 |
Why?
|
| Myocardium | 5 | 2018 | 265 | 0.720 |
Why?
|
| Scattering, Radiation | 15 | 2024 | 72 | 0.700 |
Why?
|
| Gallium Radioisotopes | 5 | 2008 | 12 | 0.630 |
Why?
|
| Coronary Circulation | 2 | 2019 | 50 | 0.630 |
Why?
|
| Monte Carlo Method | 9 | 2023 | 88 | 0.610 |
Why?
|
| Anthropometry | 3 | 2021 | 79 | 0.600 |
Why?
|
| Four-Dimensional Computed Tomography | 1 | 2018 | 5 | 0.590 |
Why?
|
| Respiratory-Gated Imaging Techniques | 2 | 2018 | 4 | 0.550 |
Why?
|
| Male | 29 | 2024 | 27948 | 0.540 |
Why?
|
| Respiratory Mechanics | 1 | 2017 | 57 | 0.540 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2017 | 2064 | 0.500 |
Why?
|
| Models, Biological | 4 | 2017 | 1146 | 0.500 |
Why?
|
| Iodine Radioisotopes | 5 | 2019 | 50 | 0.480 |
Why?
|
| Sensitivity and Specificity | 13 | 2011 | 1104 | 0.470 |
Why?
|
| Time Factors | 10 | 2024 | 3629 | 0.470 |
Why?
|
| Heart Diseases | 1 | 2017 | 207 | 0.460 |
Why?
|
| Female | 25 | 2024 | 30921 | 0.460 |
Why?
|
| Single Photon Emission Computed Tomography Computed Tomography | 3 | 2024 | 10 | 0.440 |
Why?
|
| Equipment Design | 4 | 2025 | 334 | 0.420 |
Why?
|
| Monitoring, Physiologic | 1 | 2013 | 150 | 0.400 |
Why?
|
| Middle Aged | 14 | 2024 | 16452 | 0.390 |
Why?
|
| Photons | 4 | 2021 | 25 | 0.360 |
Why?
|
| Aged | 11 | 2024 | 13512 | 0.330 |
Why?
|
| Whole Body Imaging | 1 | 2009 | 9 | 0.320 |
Why?
|
| Models, Theoretical | 13 | 2006 | 257 | 0.310 |
Why?
|
| Photography | 1 | 2009 | 40 | 0.310 |
Why?
|
| Mediastinal Neoplasms | 1 | 2008 | 17 | 0.300 |
Why?
|
| Gated Blood-Pool Imaging | 2 | 2006 | 11 | 0.300 |
Why?
|
| Citrates | 3 | 2005 | 17 | 0.280 |
Why?
|
| Gallium | 3 | 2005 | 12 | 0.280 |
Why?
|
| Tomography, Emission-Computed | 6 | 2002 | 40 | 0.270 |
Why?
|
| Signal-To-Noise Ratio | 2 | 2020 | 51 | 0.270 |
Why?
|
| Models, Statistical | 3 | 2012 | 299 | 0.270 |
Why?
|
| Oximes | 1 | 2006 | 11 | 0.260 |
Why?
|
| Organotechnetium Compounds | 1 | 2006 | 28 | 0.260 |
Why?
|
| Cardiac-Gated Imaging Techniques | 2 | 2017 | 8 | 0.250 |
Why?
|
| Abdomen | 2 | 2017 | 91 | 0.240 |
Why?
|
| Diagnostic Imaging | 2 | 2013 | 246 | 0.240 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2018 | 1540 | 0.230 |
Why?
|
| Healthy Volunteers | 2 | 2014 | 66 | 0.220 |
Why?
|
| Filtration | 6 | 1991 | 20 | 0.220 |
Why?
|
| Gymnastics | 1 | 2003 | 3 | 0.210 |
Why?
|
| Radiotherapy Dosage | 2 | 2003 | 81 | 0.210 |
Why?
|
| Stroke Volume | 6 | 2012 | 315 | 0.210 |
Why?
|
| Task Performance and Analysis | 1 | 2003 | 123 | 0.200 |
Why?
|
| Psychomotor Performance | 1 | 2003 | 133 | 0.200 |
Why?
|
| Models, Structural | 13 | 1997 | 25 | 0.190 |
Why?
|
| Hippocampus | 3 | 2017 | 251 | 0.190 |
Why?
|
| Radioactive Tracers | 1 | 2002 | 2 | 0.190 |
Why?
|
| Physics | 1 | 2002 | 12 | 0.190 |
Why?
|
| Radionuclide Imaging | 7 | 1994 | 121 | 0.190 |
Why?
|
| Blood Circulation | 2 | 2012 | 8 | 0.190 |
Why?
|
| Models, Animal | 1 | 2002 | 224 | 0.180 |
Why?
|
| Machine Learning | 2 | 2022 | 156 | 0.180 |
Why?
|
| Electrocardiography | 2 | 2013 | 524 | 0.180 |
Why?
|
| Homeostasis | 1 | 2003 | 347 | 0.180 |
Why?
|
| Analysis of Variance | 5 | 2009 | 592 | 0.170 |
Why?
|
| Coronary Artery Disease | 2 | 2018 | 277 | 0.170 |
Why?
|
| Nortropanes | 1 | 2019 | 3 | 0.170 |
Why?
|
| Neuroimaging | 1 | 2020 | 145 | 0.160 |
Why?
|
| Technetium Tc 99m Exametazime | 1 | 1999 | 3 | 0.160 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 678 | 0.150 |
Why?
|
| Area Under Curve | 1 | 2018 | 141 | 0.150 |
Why?
|
| Reference Standards | 1 | 2018 | 72 | 0.150 |
Why?
|
| Precision Medicine | 1 | 2018 | 102 | 0.140 |
Why?
|
| Adult | 7 | 2019 | 15771 | 0.140 |
Why?
|
| Receptors, Nicotinic | 2 | 2007 | 66 | 0.130 |
Why?
|
| Liver | 6 | 1998 | 798 | 0.130 |
Why?
|
| Technetium Compounds | 1 | 1996 | 5 | 0.130 |
Why?
|
| Aged, 80 and over | 4 | 2019 | 5150 | 0.120 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2016 | 46 | 0.120 |
Why?
|
| Head | 1 | 2016 | 53 | 0.120 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2014 | 96 | 0.120 |
Why?
|
| Pattern Recognition, Automated | 2 | 2005 | 52 | 0.120 |
Why?
|
| Radioisotopes | 3 | 2018 | 23 | 0.120 |
Why?
|
| Torso | 1 | 2014 | 16 | 0.110 |
Why?
|
| Sex Factors | 1 | 2017 | 940 | 0.110 |
Why?
|
| Likelihood Functions | 5 | 2002 | 68 | 0.110 |
Why?
|
| Tomography, Spiral Computed | 1 | 2013 | 21 | 0.110 |
Why?
|
| Gamma Cameras | 2 | 1999 | 6 | 0.110 |
Why?
|
| Automation | 1 | 2013 | 51 | 0.110 |
Why?
|
| Calibration | 1 | 2013 | 67 | 0.110 |
Why?
|
| Radiography, Thoracic | 3 | 1999 | 111 | 0.110 |
Why?
|
| Patient Positioning | 1 | 2013 | 46 | 0.100 |
Why?
|
| Technetium | 6 | 2002 | 68 | 0.100 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2013 | 70 | 0.100 |
Why?
|
| Artificial Intelligence | 2 | 2005 | 155 | 0.100 |
Why?
|
| Heart Rate | 1 | 2013 | 309 | 0.100 |
Why?
|
| Lymphoma | 2 | 2005 | 99 | 0.100 |
Why?
|
| Radiography | 2 | 2012 | 519 | 0.100 |
Why?
|
| Computer-Aided Design | 2 | 2009 | 26 | 0.100 |
Why?
|
| Young Adult | 2 | 2019 | 4290 | 0.090 |
Why?
|
| Normal Distribution | 3 | 2006 | 17 | 0.090 |
Why?
|
| Neoplasms | 3 | 2009 | 1238 | 0.090 |
Why?
|
| Indium | 2 | 1986 | 7 | 0.080 |
Why?
|
| Equipment Failure Analysis | 1 | 2009 | 74 | 0.080 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2009 | 43 | 0.080 |
Why?
|
| Kinetics | 2 | 2010 | 751 | 0.070 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2016 | 92 | 0.070 |
Why?
|
| Models, Cardiovascular | 2 | 1999 | 76 | 0.070 |
Why?
|
| Anabasine | 1 | 2007 | 1 | 0.070 |
Why?
|
| Cholinergic Fibers | 1 | 2007 | 4 | 0.070 |
Why?
|
| Space Perception | 1 | 2007 | 19 | 0.070 |
Why?
|
| Nerve Degeneration | 1 | 2007 | 70 | 0.070 |
Why?
|
| Amyloid | 1 | 2007 | 65 | 0.070 |
Why?
|
| Neuroprotective Agents | 1 | 2007 | 72 | 0.070 |
Why?
|
| Liver Neoplasms | 2 | 2000 | 277 | 0.070 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2006 | 6 | 0.070 |
Why?
|
| Information Storage and Retrieval | 1 | 2006 | 60 | 0.060 |
Why?
|
| Thorax | 3 | 2001 | 34 | 0.060 |
Why?
|
| Back | 1 | 2005 | 4 | 0.060 |
Why?
|
| Mathematics | 3 | 1996 | 32 | 0.060 |
Why?
|
| Nevus, Pigmented | 1 | 2005 | 19 | 0.060 |
Why?
|
| tau Proteins | 1 | 2007 | 191 | 0.060 |
Why?
|
| Observer Variation | 5 | 2005 | 206 | 0.060 |
Why?
|
| Torque | 1 | 2003 | 15 | 0.050 |
Why?
|
| Stochastic Processes | 1 | 2003 | 26 | 0.050 |
Why?
|
| Quality Control | 1 | 2003 | 71 | 0.050 |
Why?
|
| Posture | 1 | 2003 | 127 | 0.050 |
Why?
|
| Postural Balance | 1 | 2003 | 60 | 0.050 |
Why?
|
| Coronary Disease | 2 | 2001 | 246 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2003 | 117 | 0.050 |
Why?
|
| Physical Phenomena | 1 | 2002 | 9 | 0.050 |
Why?
|
| Muscle Contraction | 1 | 2003 | 197 | 0.050 |
Why?
|
| Neurons | 1 | 2007 | 865 | 0.050 |
Why?
|
| Radiometry | 2 | 2018 | 35 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2003 | 229 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2005 | 398 | 0.040 |
Why?
|
| Thoracic Neoplasms | 1 | 2000 | 12 | 0.040 |
Why?
|
| Reference Values | 2 | 2017 | 330 | 0.040 |
Why?
|
| Diphosphates | 1 | 1980 | 10 | 0.040 |
Why?
|
| Subtraction Technique | 1 | 1999 | 23 | 0.040 |
Why?
|
| Bone and Bones | 1 | 1980 | 136 | 0.040 |
Why?
|
| Cardiac Volume | 1 | 1998 | 7 | 0.040 |
Why?
|
| Cervical Vertebrae | 1 | 1999 | 101 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 1999 | 175 | 0.040 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 2 | 2007 | 7 | 0.030 |
Why?
|
| Nicotinic Agonists | 2 | 2007 | 39 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2019 | 6152 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 2016 | 63 | 0.030 |
Why?
|
| Probability | 1 | 1996 | 170 | 0.030 |
Why?
|
| Animals | 6 | 2007 | 19702 | 0.030 |
Why?
|
| Thallium Radioisotopes | 1 | 1994 | 9 | 0.030 |
Why?
|
| Technology, Radiologic | 1 | 1992 | 9 | 0.020 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 1992 | 55 | 0.020 |
Why?
|
| Discriminant Analysis | 1 | 2010 | 18 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2010 | 56 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2007 | 3240 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2010 | 248 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 2000 | 288 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 158 | 0.020 |
Why?
|
| Myocardial Contraction | 2 | 1999 | 85 | 0.020 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2007 | 7 | 0.020 |
Why?
|
| Axotomy | 1 | 2007 | 8 | 0.020 |
Why?
|
| Fornix, Brain | 1 | 2007 | 10 | 0.020 |
Why?
|
| Child | 1 | 2017 | 4212 | 0.020 |
Why?
|
| Schizophrenia | 1 | 1989 | 247 | 0.020 |
Why?
|
| Spleen | 2 | 1988 | 480 | 0.020 |
Why?
|
| Aconitine | 1 | 2007 | 1 | 0.020 |
Why?
|
| Benzylidene Compounds | 1 | 2007 | 1 | 0.020 |
Why?
|
| Nicotinic Antagonists | 1 | 2007 | 19 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2007 | 73 | 0.020 |
Why?
|
| Maze Learning | 1 | 2007 | 50 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2007 | 127 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2007 | 137 | 0.020 |
Why?
|
| Septal Nuclei | 1 | 2007 | 52 | 0.020 |
Why?
|
| Health Physics | 1 | 1986 | 6 | 0.020 |
Why?
|
| Biometry | 1 | 1986 | 11 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 5865 | 0.020 |
Why?
|
| Pyridines | 1 | 2007 | 99 | 0.020 |
Why?
|
| Myristic Acids | 1 | 1986 | 5 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2007 | 476 | 0.020 |
Why?
|
| Cell Survival | 1 | 2007 | 560 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2007 | 219 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2007 | 305 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2007 | 886 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2007 | 1207 | 0.010 |
Why?
|
| Hindlimb | 2 | 1982 | 44 | 0.010 |
Why?
|
| Exercise Test | 1 | 2005 | 242 | 0.010 |
Why?
|
| Mice | 2 | 2007 | 10316 | 0.010 |
Why?
|
| Rats | 1 | 2007 | 1911 | 0.010 |
Why?
|
| Oxyquinoline | 1 | 1982 | 2 | 0.010 |
Why?
|
| Hydroxyquinolines | 1 | 1982 | 3 | 0.010 |
Why?
|
| Rabbits | 2 | 1982 | 326 | 0.010 |
Why?
|
| Glucose | 1 | 1986 | 444 | 0.010 |
Why?
|
| Osteomyelitis | 1 | 1982 | 24 | 0.010 |
Why?
|
| Cell Line | 1 | 2007 | 1987 | 0.010 |
Why?
|
| Leukocytes | 1 | 1982 | 97 | 0.010 |
Why?
|
| Protein Binding | 1 | 2007 | 1556 | 0.010 |
Why?
|
| Biophysical Phenomena | 1 | 2002 | 22 | 0.010 |
Why?
|
| Organometallic Compounds | 1 | 1982 | 63 | 0.010 |
Why?
|
| Biophysics | 1 | 2002 | 41 | 0.010 |
Why?
|
| Insulin | 1 | 1986 | 672 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2007 | 2000 | 0.010 |
Why?
|
| Gadolinium | 1 | 2002 | 103 | 0.010 |
Why?
|
| Prognosis | 1 | 2005 | 1613 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2007 | 682 | 0.010 |
Why?
|
| Poisson Distribution | 1 | 2000 | 52 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 2060 | 0.010 |
Why?
|
| Autoradiography | 1 | 1980 | 53 | 0.010 |
Why?
|
| Body Surface Potential Mapping | 1 | 1999 | 4 | 0.010 |
Why?
|
| X-Rays | 1 | 1980 | 45 | 0.010 |
Why?
|
| Systole | 1 | 1999 | 109 | 0.010 |
Why?
|
| Diastole | 1 | 1999 | 89 | 0.010 |
Why?
|
| Body Constitution | 1 | 1999 | 16 | 0.010 |
Why?
|
| Efficiency | 1 | 1999 | 38 | 0.010 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 1999 | 69 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 1999 | 242 | 0.010 |
Why?
|
| Diffusion | 1 | 1998 | 82 | 0.010 |
Why?
|
| Ventricular Function, Right | 1 | 1997 | 27 | 0.010 |
Why?
|
| Ribs | 1 | 1997 | 4 | 0.010 |
Why?
|
| Sternum | 1 | 1997 | 29 | 0.010 |
Why?
|
| Spine | 1 | 1997 | 42 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 1997 | 258 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2000 | 837 | 0.010 |
Why?
|
| Radioimmunotherapy | 1 | 1992 | 7 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1992 | 103 | 0.010 |
Why?
|
| Lung | 1 | 1997 | 926 | 0.010 |
Why?
|
| Water | 1 | 1992 | 300 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 1989 | 64 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1989 | 108 | 0.000 |
Why?
|
| Radiation | 1 | 1988 | 4 | 0.000 |
Why?
|
| Statistics as Topic | 1 | 1988 | 146 | 0.000 |
Why?
|
| Dogs | 1 | 1986 | 316 | 0.000 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 1982 | 4 | 0.000 |
Why?
|
| Diphosphonates | 1 | 1982 | 32 | 0.000 |
Why?
|
| Staphylococcus aureus | 1 | 1982 | 170 | 0.000 |
Why?
|